ANZMTG 01.02/TROG 02.01 - TROG Cancer Research

By w.paterson
14 August, 2021
0 Comments

A Randomised Clinical Trial of Surgery Versus Surgery Plus Adjuvant Radiotherapy for Regional Control in Patients With Completely Resected Nodal Metastatic Melanoma

Primary Sponsor

15 October, 2024

Diversity, equity and inclusion at heart of TROG work

15 October 2024: TROG Cancer Research has made a

1 October, 2024

A plan for the future of cancer research

12 September 2024: TROG Cancer Research has outlined how

Join us to raise $20,000

For over 30 years, Trans-Tasman Radiation Oncology Group has been dedicated to improving the way radiation medicine is delivered to cancer patients with ongoing scientific research, clinical trials, and cutting-edge technology.

Quick Links

Legalities

A Randomised Clinical Trial of Surgery Versus Surgery Plus Adjuvant Radiotherapy for Regional Control in Patients With Completely Resected Nodal Metastatic Melanoma

CPRR04-EFC4690/TROG 02.02 – HEADSTART

TROG 01.05 – Superdex/Spinal Cord Compression

Related Post

Diversity, equity and inclusion at heart of TROG work

A plan for the future of cancer research

Join us to raise $20,000